journal article·2024-02Open access

Tissue formation and host remodeling of an elastomeric biodegradable scaffold in an ovine pulmonary leaflet replacement model

Zurab Machaidze, Antonio D'Amore, Renata C. C. Freitas, Angelina J. Joyce, Ahmed Bayoumi, Kimberly Rich, David W. Brown, Elena Aikawa, William R. Wagner, Bruno V. Rego, John E. Mayer

Abstract

Abstract In pursuit of a suitable scaffold material for cardiac valve tissue engineering applications, an acellular, electrospun, biodegradable polyester carbonate urethane urea (PECUU) scaffold was evaluated as a pulmonary valve leaflet replacement in vivo. In sheep (n = 8), a single pulmonary valve leaflet was replaced with a PECUU leaflet and followed for 1, 6, and 12 weeks. Implanted leaflet function was assessed in vivo by echocardiography. Explanted samples were studied for gross pathology, microscopic changes in the extracellular matrix, host cellular re‐population, and immune responses, and for biomechanical properties. PECUU leaflets showed normal leaflet motion at implant, but decreased leaflet motion and dimensions at 6 weeks. The leaflets accumulated α‐SMA and CD45 positive cells, with surfaces covered with endothelial cells (CD31+). New collagen formation occurred (Picrosirius Red). Accumulated tissue thickness correlated with the decrease in leaflet motion. The PECUU scaffolds had histologic evidence of scaffold degradation and an accumulation of pro‐inflammatory/M1 and anti‐inflammatory/M2 macrophages over time in vivo. The extent of inflammatory cell accumulation correlated with tissue formation and polymer degradation but was also associated with leaflet thickening and decreased leaflet motion. Future studies should explore pre‐implant seeding of polymer scaffolds, more advanced polymer fabrication methods able to more closely approximate native tissue structure and function, and other techniques to control and balance the degradation of biomaterials and new tissue formation by modulation of the host immune response.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Aortic Disease and Treatment Approaches

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiac Surgery Boston Children's Hospital, Harvard Medical School Boston Massachusetts USA

McGowan Institute for Regenerative Medicine, Departments of Surgery and Bioengineering University of Pittsburgh Pittsburgh Pennsylvania USA

RiMED Cardiac Tissue Engineering Laboratory Fondazione RiMED Palermo Italy

Department of Cardiology Boston Children's Hospital, Harvard Medical School Boston Massachusetts USA

Center for Excellence in Vascular Biology Brigham and Women's Hospital, Harvard Medical School Boston Massachusetts USA

Department of Biological & Agricultural Engineering Louisiana State University Baton Rouge Louisiana USA

Funding

National Heart, Lung, and Blood Institute · National Institutes of Health · National Science Foundation

References (45)

Show source-provided references
1. 10.1161/01.cir.0000441139.02102.8010.1161/01.cir.0000441139.02102.80 ↗
2. 10.1161/CIRCULATIONAHA.115.01930710.1161/CIRCULATIONAHA.115.019307 ↗
3. 10.3389/fbioe.2019.0008710.3389/fbioe.2019.00087 ↗
4. 10.1038/s41569‐020‐0422‐810.1038/s41569‐020‐0422‐8 ↗
5. 10.1016/j.biomaterials.2017.02.00710.1016/j.biomaterials.2017.02.007 ↗
6. 10.1016/j.biomaterials.2017.10.01110.1016/j.biomaterials.2017.10.011 ↗
7. 10.1016/j.biomaterials.2013.06.02010.1016/j.biomaterials.2013.06.020 ↗
8. 10.1002/adhm.20200215310.1002/adhm.202002153 ↗
9. 10.1016/j.jbiomech.2013.05.01510.1016/j.jbiomech.2013.05.015 ↗
10. 10.1046/j.1525‐1594.2002.07004.x10.1046/j.1525‐1594.2002.07004.x ↗
11. 10.1016/j.actbio.2016.10.03210.1016/j.actbio.2016.10.032 ↗
12. 10.1242/jcs.0035910.1242/jcs.00359 ↗
13. 10.1242/jcs.0036010.1242/jcs.00360 ↗
14. 10.1088/0034‐4885/77/4/04660310.1088/0034‐4885/77/4/046603 ↗
15. 10.1007/s10439‐016‐1605‐710.1007/s10439‐016‐1605‐7 ↗
16. 10.1016/j.jtcvs.2009.11.00610.1016/j.jtcvs.2009.11.006 ↗
17. 10.1016/j.biomaterials.2010.02.00510.1016/j.biomaterials.2010.02.005 ↗
18. 10.1016/j.jbiomech.2012.11.04610.1016/j.jbiomech.2012.11.046 ↗
19. 10.1016/j.jbiomech.2012.01.03110.1016/j.jbiomech.2012.01.031 ↗
20. 10.1016/j.athoracsur.2013.04.08510.1016/j.athoracsur.2013.04.085 ↗
21. 10.1016/j.biomaterials.2010.01.05110.1016/j.biomaterials.2010.01.051 ↗
22. Tissue‐engineered heart valves. Autologous valve leaflet replacement study in a lamb model
23. 10.1007/s10439‐006‐9183‐810.1007/s10439‐006‐9183‐8 ↗
24. 10.1007/s10439‐005‐9027‐y10.1007/s10439‐005‐9027‐y ↗
25. 10.1115/1.128715810.1115/1.1287158 ↗
26. Rego BV · 2015 · SB3C2015
27. 10.1115/1.402926610.1115/1.4029266 ↗
28. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves
29. 10.1161/CIRCULATIONAHA.105.59176810.1161/CIRCULATIONAHA.105.591768 ↗
30. 10.1152/physiol.00029.201310.1152/physiol.00029.2013 ↗
31. 10.1089/ten.TEA.2009.001810.1089/ten.TEA.2009.0018 ↗
32. 10.1016/j.biomaterials.2013.04.05910.1016/j.biomaterials.2013.04.059 ↗
33. 10.1161/CIRCULATIONAHA.104.49837810.1161/CIRCULATIONAHA.104.498378 ↗
34. 10.1016/j.biomaterials.2010.01.13510.1016/j.biomaterials.2010.01.135 ↗
35. 10.1038/s41536‐017‐0023‐210.1038/s41536‐017‐0023‐2 ↗
36. 10.1038/emm.2013.11810.1038/emm.2013.118 ↗
37. 10.1016/j.actbio.2011.11.03110.1016/j.actbio.2011.11.031 ↗
38. 10.1089/ten.tea.2007.026410.1089/ten.tea.2007.0264 ↗
39. 10.1016/j.jtcvs.2017.01.05210.1016/j.jtcvs.2017.01.052 ↗
40. 10.1016/j.it.2004.09.01510.1016/j.it.2004.09.015 ↗
41. 10.1002/jbm.1028610.1002/jbm.10286 ↗
42. 10.1016/j.biomaterials.2005.05.07910.1016/j.biomaterials.2005.05.079 ↗
43. 10.1002/jbm.a.3050610.1002/jbm.a.30506 ↗
44. 10.1089/ten.TEA.2015.006610.1089/ten.TEA.2015.0066 ↗
45. 10.1096/fj.11‐18224610.1096/fj.11‐182246 ↗